Thousand red biochemistry denies fictitious information media report two big questions

Thousand red biochemical pharmaceutical company yesterday to the media two major questions to clarify.　　(Information picture) (reporter Ye Jing) has just released a prospectus of the thousand red Pharmaceutical, the recent media has been questioned. Sources said the company suspected in the prospectus of the company to obtain the EU CEP certificate information, and deliberately conceal the 2008 Gansu products were Germany requested recall information. After the news broke, the red pharmaceutical has been in a state of silence, so that the market can not help wondering whether there will be suspended listing of listed companies.　　Yesterday, the reporter calls Thousand red pharmacy, the related person in charge to the reporter made clear that before the media questioned the two points of the problem is not true. Media reports two major questions before, according to media reports, Red pharmaceutical in the prospectus fictitious the company to obtain the EU CEP Certificate of information, which means that it in the prospectus described in the many facts and advantages do not set.　　In addition, because of quality problems, the red pharmaceutical heparin products were in 2008 by the German pharmaceutical regulatory authorities to recall the request, which is also deliberately concealed in its prospectus. The reporter called the Red Biochemical pharmaceutical company, the company's relevant officials are in Shenzhen Road show. He told reporters that he had seen media reports, but they thought the content was not true, and therefore has not made a formal response. I did not expect to see more and more recent reports, and decided to respond positively. The issue of certificates is already commented on in the prospectus, and different search methods will result in deviations.　　If it is not possible to sell products in EU countries without obtaining a certificate, the company will not have the current market share in the EU market. Certificate does not exist fictitious prospectus shows that the Red Pharmaceutical in July 2003 for the first time commissioned by the German helm company to apply for EU COS certification (European Pharmacopoeia Applicability certification), the European Drug Quality Administration (EDQM) officially issued a Heparin Sodium API CEP certificate.　　After the thousand red Pharmaceutical and successfully passed a number of certification. Thousand Red Pharmaceutical said that the German company (Helm) is a well-known European pharmaceutical and chemical products, such as traders, by the company commissioned Helm as a heparin Sodium API products agents to the EU relevant drug regulatory authorities to apply for a CEP certificate, which contains the certificate of the person Helm, Certified products for the company in Changzhou, China, Jiangsu factory production of heparin sodium raw materials, the company as the corresponding product manufacturer is not to be changed.　　The above CEP certificate as the company's Heparin Sodium API product quality certification within the EU, as well as the EU-related drug buyers are effective. After the company through CEP certification, in addition to helm, the company's heparin sodium raw materials products also gradually opened up the German forest company, Austrian mountain Texaco Company, Italy Austrian glass company, such as a group of European well-known heparin preparation manufacturer customers, the company in the European market share gradually rise.　　Therefore, the helm company as a CEP certificate holder has not adversely affected the company's development in the European market. Product quality suspicion has been ruled out and about 2008A product quality issue that was recalled by German Drug Administration regulators, the company said March 24, 2008 that the red heparin became contaminated with suspicion has been ruled out. The company said March 7, 2008, the Wall Street Journal reported that a document issued by the German Ministry of Health, Land Schleswig-holstein, said the active ingredient used in the country's three batches of recalled Heparin was produced by China's Changzhou thousand-Red Pharmaceutical Co., Ltd. and a company. On March 24, 2008, the Wall Street Journal released a follow-up report that confirmed that the ingredients of the recalled heparin had been tested to remove suspicion of contamination of the red heparin ingredient. 1 minutes, 2 minutes, 3 minutes, 4 minutes, 5 minutes.